In light of the aforementioned evidence, we proposed that ERRα as a direct target of ERα may contribute to the TMX-induced NAFLD via additionally blunting hepatic VLDL assembly and secretion. The gene discussed is ESRRA; the disease is metabolic dysfunction-associated steatotic liver disease.